• 

  VIETNAM | Ministry of Health Updates Drug Registration Framework — Post-Authorisation Evidence Requirements Continue

  Gallery

  VIETNAM | Ministry of Health Updates Drug Registration Framework — Post-Authorisation Evidence Requirements Continue

  2026, August 2026, Members-Only, Minor Update, Vietnam
• 

VIETNAM | Ministry of Health Updates Drug Registration Framework — Post-Authorisation Evidence Requirements Continue

Please login to view this page.

VIETNAM | Ministry of Health Updates Drug Registration Framework — Post-Authorisation Evidence Requirements Continuestuart.mccully2026-09-12T17:14:16+00:00

• 

  UK | MHRA Advises Against Infant Use of Rectal Catheters — Lack of Clinical Evidence Drives Device Safety Action

  Gallery

  UK | MHRA Advises Against Infant Use of Rectal Catheters — Lack of Clinical Evidence Drives Device Safety Action

  2026, August 2026, Medical Devices, Members-Only, Minor Update, UK
• 

UK | MHRA Advises Against Infant Use of Rectal Catheters — Lack of Clinical Evidence Drives Device Safety Action

Please login to view this page.

UK | MHRA Advises Against Infant Use of Rectal Catheters — Lack of Clinical Evidence Drives Device Safety Actionstuart.mccully2026-09-12T17:05:12+00:00

• 

  UK | MHRA Reaffirms Childhood Vaccine Safety — Real-World Data Underpins Continuous Surveillance

  Gallery

  UK | MHRA Reaffirms Childhood Vaccine Safety — Real-World Data Underpins Continuous Surveillance

  2026, August 2026, Members-Only, Minor Update, UK
• 

UK | MHRA Reaffirms Childhood Vaccine Safety — Real-World Data Underpins Continuous Surveillance

Please login to view this page.

UK | MHRA Reaffirms Childhood Vaccine Safety — Real-World Data Underpins Continuous Surveillancestuart.mccully2026-09-12T17:02:14+00:00

• 

  UK | HRA Backs Rare Disease Pathway — But Says Real-World Evidence Needs Clear Governance

  Gallery

  UK | HRA Backs Rare Disease Pathway — But Says Real-World Evidence Needs Clear Governance

  2026, August 2026, Members-Only, Minor Update, Rare Diseases, UK
• 

UK | HRA Backs Rare Disease Pathway — But Says Real-World Evidence Needs Clear Governance

Please login to view this page.

UK | HRA Backs Rare Disease Pathway — But Says Real-World Evidence Needs Clear Governancestuart.mccully2026-09-12T16:58:04+00:00

• 

  EU | JRC Warns Biological AI Is Advancing Faster Than Its Real-World Readiness — Strong Performance Does Not Yet Mean Models Are Ready for Clinical Use

  Gallery

  EU | JRC Warns Biological AI Is Advancing Faster Than Its Real-World Readiness — Strong Performance Does Not Yet Mean Models Are Ready for Clinical Use

  2026, AI, EU, Members-Only, Minor Update
• 

EU | JRC Warns Biological AI Is Advancing Faster Than Its Real-World Readiness — Strong Performance Does Not Yet Mean Models Are Ready for Clinical Use

Please login to view this page.

EU | JRC Warns Biological AI Is Advancing Faster Than Its Real-World Readiness — Strong Performance Does Not Yet Mean Models Are Ready for Clinical Usestuart.mccully2026-09-12T16:40:21+00:00

• 

  EU | EMA and HMA Consult on Data Standards Framework — Formalising How the Regulatory Network Manages Data Standards

  Gallery

  EU | EMA and HMA Consult on Data Standards Framework — Formalising How the Regulatory Network Manages Data Standards

  2026, August 2026, EMA, EU, Members-Only, Minor Update
• 

EU | EMA and HMA Consult on Data Standards Framework — Formalising How the Regulatory Network Manages Data Standards

Please login to view this page.

EU | EMA and HMA Consult on Data Standards Framework — Formalising How the Regulatory Network Manages Data Standardsstuart.mccully2026-09-12T15:47:45+00:00

EU | European Medicines Regulatory Network Identifies AI Research Priorities — Reliability, Data Governance and Bias Lead the Agenda

Please login to view this page.

EU | European Medicines Regulatory Network Identifies AI Research Priorities — Reliability, Data Governance and Bias Lead the Agendastuart.mccully2026-09-12T15:38:33+00:00

• 

  EU | EMA Consults on Qualification of Multinational MS Registry Network for Post-Authorisation Safety Studies

  Gallery

  EU | EMA Consults on Qualification of Multinational MS Registry Network for Post-Authorisation Safety Studies

  2026, EU, Members-Only, Minor Update
• 

EU | EMA Consults on Qualification of Multinational MS Registry Network for Post-Authorisation Safety Studies

Please login to view this page.

EU | EMA Consults on Qualification of Multinational MS Registry Network for Post-Authorisation Safety Studiesstuart.mccully2026-09-12T15:32:44+00:00

• 

  EU | Article 50 AI Transparency Requirements Now Apply — Human Review Exception Important for RWR Publications

  Gallery

  EU | Article 50 AI Transparency Requirements Now Apply — Human Review Exception Important for RWR Publications

  2026, AI, August 2026, EU, Members-Only, Minor Update
• 

EU | Article 50 AI Transparency Requirements Now Apply — Human Review Exception Important for RWR Publications

Please login to view this page.

EU | Article 50 AI Transparency Requirements Now Apply — Human Review Exception Important for RWR Publicationsstuart.mccully2026-09-12T15:27:59+00:00

• 

  EU | Digital Omnibus Resets High-Risk AI Timelines and Expands Rules for Bias and Real-World Testing

  Gallery

  EU | Digital Omnibus Resets High-Risk AI Timelines and Expands Rules for Bias and Real-World Testing

  2026, AI, August 2026, EU, Members-Only, Minor Update
• 

EU | Digital Omnibus Resets High-Risk AI Timelines and Expands Rules for Bias and Real-World Testing

Please login to view this page.

EU | Digital Omnibus Resets High-Risk AI Timelines and Expands Rules for Bias and Real-World Testingstuart.mccully2026-09-12T15:23:35+00:00